Cancer Institute of New Jersey (CINJ), Division of Surgical Oncology, Melanoma & Soft Tissue Oncology

Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Melanoma Medicine & Life Sciences
Riluzole Medicine & Life Sciences
Skin Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Skin Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Hispanic Americans Medicine & Life Sciences
Sentinel Lymph Node Biopsy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Profiles

No photo of Vadim Koshenkov

Vadim Koshenkov

Person

20112017

Projects 2010 2015

A Patient Oriented Research Program For Surgical Oncologists

Goydos, J.

National Institutes of Health (NIH)

7/5/10 → 6/30/15

Project: Research project

Melanoma
Riluzole
Translational Medical Research
Research
Medical Laboratory Science

Combination Therapy That Targets Glutamate Signaling In Melanoma

Goydos, J.

National Institutes of Health (NIH)

4/22/10 → 1/31/15

Project: Research project

Glutamic Acid
Melanoma
Riluzole
Therapeutics
Carcinogenesis

Research Output 1996 2018

Activation of Grm1 expression by mutated BRaf (V600E) in vitro and in vivo

Chen, H. C., Sierra, J., Yu, L. J., Cerchio, R., Wall, B. A., Goydos, J. & Chen, S., Jan 1 2018, In : Oncotarget. 9, 5, p. 5861-5875 15 p.

Research output: Contribution to journal › Article

Melanocytes
Melanoma
Penetrance
Cell Aging
Nevus
3 Citations (Scopus)

A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma

Mehnert, J., Silk, A., Lee, J. H., Dudek, L., Jeong, B. S., Li, J., Schenkel, J. M., Sadimin, E., Kane, M., Lin, H., Shih, W., Zloza, A., Chen, S. & Goydos, J., Jul 1 2018, In : Pigment Cell and Melanoma Research. 31, 4, p. 534-540 7 p.

Research output: Contribution to journal › Article

Riluzole
Tumors
Melanoma
Pharmacokinetics
Down-Regulation
2 Citations (Scopus)

Exosomes released by metabotropic glutamate receptor 1 (GRM1) expressing melanoma cells increase cell migration and invasiveness

Isola, A. L., Eddy, K., Zembrzuski, K., Goydos, J. & Chen, S., Jan 1 2018, In : Oncotarget. 9, 1, p. 1187-1199 13 p.

Research output: Contribution to journal › Article

Exosomes
Cell Movement
Melanoma
Cellular Microenvironment
Neoplasms